期刊文献+
共找到155篇文章
< 1 2 8 >
每页显示 20 50 100
Reliability of a Tissue Microarray in Detecting Thyroid Transcription Factor-1 Protein in Lung Carcinomas 被引量:1
1
作者 Xiaoyan Bai Hong Shen 《Chinese Journal of Clinical Oncology》 CSCD 2007年第1期9-15,共7页
OBJECTIVE To compare the expression of the thyroid transcription factor-1 (TTF-1) in human normal adult type Ⅱ alveolar epithelial cells, embryonic pneumocytes and cancer cells of lung carcinoma and metastatic lymp... OBJECTIVE To compare the expression of the thyroid transcription factor-1 (TTF-1) in human normal adult type Ⅱ alveolar epithelial cells, embryonic pneumocytes and cancer cells of lung carcinoma and metastatic lymph nodes using a tissue microarray (TMA) along with paired conventional full sections, and to investigate the reliability of tissue microarrays in detecting protein expression in lung carcinoma. METHODS A lung carcinoma TMA including 765 cores was constructed. TTF-1 protein expression in both TMA and paired conventional full sections were detected by the immunohistochemical SP method using a monoclonal antibody to TTF-1. A PU (Positive Unit) of TTF-1 protein was assessed quantitatively by the Leica Q500MC image analysis system with results from the paired conventional full sections as controls. RESULTS There was no significance between TMA and paired conventional full sections in TTF-1 expression in different nuclei of the lung tissue. CONCLUSION TTF-1 protein expression in lung carcinoma detected by TMA was highly concordant with that of paired full sections. TMA is a reliable method in detecting protein expression. 展开更多
关键词 lung carcinoma transcription factor-1(TTF-1) liability. tissue microarray thyroid immunohistochemistry reliability.
下载PDF
E-cadherin and β-catenin expression in pancreatic intraepithelial neoplasia and pancreatic adenocarcinoma
2
作者 郑建明 朱明华 +4 位作者 倪灿荣 于观贞 王炜 林万和 龚志锦 《Journal of Medical Colleges of PLA(China)》 CAS 2005年第1期27-32,共6页
Objective: To investigate the significance of abnormal E-cadherin and β-catenin expression in pancreatic intraepithelial neoplasia (PanIN) and pancreatic adenocarcinoma. Methods:Pancreatic samples of 156 cases were r... Objective: To investigate the significance of abnormal E-cadherin and β-catenin expression in pancreatic intraepithelial neoplasia (PanIN) and pancreatic adenocarcinoma. Methods:Pancreatic samples of 156 cases were retrospectively studied from surgery and autopsy in Changhai hospital from January 2001 to December 2003, from which tissue microarray blocks containing 129 PanIN-1A lesions, 104 PanIN-1B lesions, 22 PanIN-2 lesions, 11 PanIN-3 lesions, and 121 pancreatic ductal adenocarcinomas and corresponding paracancerous tissues were constructed. EnVision method of immunohistochemistry was used to detect the E-cadherin and β-catenin expression. The correlation between the abnormal E-cadherin and β-catenin expression and clinicopathological parameters was analysed. Results: The rate of E-cadherin abnormal expression was significant in ductal adenocarcinomas compared with the PanIN lesions and normal ducts(64.5%,32.3%,0%), moreover, the rate of E-cadherin abnormal expression was in relation to differentiation, lymph node metastasis and perineural invasion of pancreatic adenocarcinoma(P<0.05). There was remarkable increase in the E-cadherin cytoplasmic expression in PanIN lesions and ductal adenocarcinomas compared with normal ducts. The rate of β-catenin abnormal expression was found to be related with lymph node metastasis and perineural invasion of pancreatic adenocarcinoma(P<0.05). The expression of β-catenin cytoplasm and/or nucleus was significant in high-grade PanIN lesions and ductal adenocarcinomas compared with low grade PanIN lesions or normal ducts(P<0.05). There was a positive relationship between the E-cadherin and β-catenin expression in PanIN lesions and ductal adenocarcinomas (P<0.01, P<0.05). Conclusion: There is aberration in the expression of the E-cadherin and β-catenin in PanIN lesions and ductal adenocarcinomas, suggesting the E-cadherin and β-catenin changes is not only related with the biological action and prognosis, but also involved in pancreatic carcinogenesis. 展开更多
关键词 pancreatic intraepithelial neoplasia (PanIN) pancreatic neoplasms Β-CATENIN tissue microarray(TMA) E-CADHERIN immunohistochemistry
下载PDF
Overexpression of IQGAP1 in human pancreatic cancer 被引量:3
3
作者 Xiao-Xia Wang Xiao-Zhong Li +3 位作者 Li-Qin Zhai Zhi-Rong Liu Xian-Jiu Chen Yi Pei 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2013年第5期540-545,共6页
BACKGROUND:Pancreatic cancer is a highly aggressive malignant tumor with the lowest survival rate.A better understanding of the molecular mechanisms which contribute to pancreatic cancer occurrence and progression wil... BACKGROUND:Pancreatic cancer is a highly aggressive malignant tumor with the lowest survival rate.A better understanding of the molecular mechanisms which contribute to pancreatic cancer occurrence and progression will aid in the development of new approaches to the early diagnosis,prevention,and treatment of this deadly disease.The scaffold protein IQGAP1 shows elevated levels in a variety of cancer types.Currently,we investigated whether or not IQGAP1 is also overexpressed in pancreatic cancer.METHODS:IQGAP1 expression was examined in pancreatic cancer and normal tissues adjacent to cancerous tissues(adjacent tissues)by Western blotting and real-time RT-PCR as well as in paraffin sections of tissue microarray by immunohistochemistry.The correlations between IQGAP1 expression and various clinicopathological characteristics were analyzed.RESULTS:Western blotting and real-time RT-PCR revealed that the levels of IQGAP1 protein and mRNA expression in pancreatic cancer tissues were significantly increased compared with adjacent tissues.Immunohistochemistry analysis on tissue microarray showed that IQGAP1 protein expression was significantly higher in pancreatic cancer(80.0%,48/60)compared with adjacent tissues(18.3%,11/60)(P【0.001).Moreover,overexpression of IQGAP1 was shown to be associated with the grades of tumor differentiation(P【0.05).CONCLUSION:The overexpression of IQGAP1 may play an important role in pancreatic cancer occurrence and progression,and IQGAP1 may serve as a novel molecular target for the diagnosis and treatment of pancreatic cancer. 展开更多
关键词 IQGAP1 pancreatic cancer tissue microarray immunohistochemistry
下载PDF
Prognostic significance of epidermal growth factor-like domain 7 in pancreatic cancer 被引量:6
4
作者 Li Zhou Jian Li +7 位作者 Yu-Pei Zhao Jun-Chao Guo Quan-Cai Cui Wei-Xun Zhou Tai-Ping Zhang Wen-Ming Wu Lei You Hong Shu 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2014年第5期523-528,共6页
BACKGROUND: Recent studies have shown the clinical significance of epidermal growth factor-like domain 7(EGFL7)in a variety of cancers. However, the relationship between EGFL7 and the prognosis of pancreatic cancer... BACKGROUND: Recent studies have shown the clinical significance of epidermal growth factor-like domain 7(EGFL7)in a variety of cancers. However, the relationship between EGFL7 and the prognosis of pancreatic cancer(PC) remains unclear. The present study was undertaken to investigate the role of EGFL7 in the prognosis of PC.METHODS: The expression of EGFL7 in nine PC cell lines was first determined by Western blotting analysis. Tissue microarray-based immunohistochemical staining was performed in paired formalin-fixed paraffin-embedded tumor and non-tumor samples from 83 patients with PC. Finally,correlations between EGFL7 expression and clinicopathological variables as well as overall survival were evaluated.RESULTS: EGFL7 was widely expressed in all PC cell lines tested.EGFL7 expression in tumor tissues was significantly higher than that in non-tumor tissues(P0.040). In addition, univariate analysis revealed that high EGFL7 expression in tumor tissues was significantly associated with poor overall survival,accompanied by several conventional clinicopathological variables, such as gender, histological grade and lymph node metastasis. In a multivariate Cox regression test, EGFL7 expression was identified as an independent marker for longterm outcome of PC.CONCLUSION: Our data showed that EGFL7 is extensively expressed in PC and that EGFL7 is associated with poor prognosis. 展开更多
关键词 epidermal growth factor-like domain 7 pancreatic cancer prognosis Western blotting immunohistochemistry tissue microarray
下载PDF
结直肠癌中RegⅣ和EGFR的表达及临床意义 被引量:5
5
作者 王林娜 侯素平 +2 位作者 刘洪博 孙晓玲 张晓娟 《临床与实验病理学杂志》 CAS CSCD 北大核心 2015年第12期1352-1355,共4页
目的探讨RegⅣ与EGFR在结直肠癌(colorectal cancer,CRC)组织及正常结直肠黏膜组织中的表达,并分析二者表达与临床病理特征的关系。方法采用免疫组化结合组织芯片法检测92例CRC组织及对应正常黏膜组织(距癌边缘>5 cm)中RegⅣ与EGFR... 目的探讨RegⅣ与EGFR在结直肠癌(colorectal cancer,CRC)组织及正常结直肠黏膜组织中的表达,并分析二者表达与临床病理特征的关系。方法采用免疫组化结合组织芯片法检测92例CRC组织及对应正常黏膜组织(距癌边缘>5 cm)中RegⅣ与EGFR的表达,并分析二者表达的相关性。结果 (1)CRC组织与正常黏膜组织中RegⅣ的阳性率分别为53.3%(49/92)与8.7%(8/92);EGFR的阳性率分别为55.4%(51/92)、4.3%(4/92)。RegⅣ与EGFR在CRC组织中的表达均高于正常黏膜组织(P<0.05)。(2)REGⅣ与EGFR的表达与CRC分化程度、淋巴结转移及TNM分期密切相关(P<0.05),二者表达与患者性别、年龄、肿物大小以及浸润深度均无关(P>0.05)。(3)CRC组织中RegⅣ与EGFR的表达呈正相关(rs=0.343,P=0.001)。结论 RegⅣ与EGFR在CRC组织内的表达均增高,并且呈正相关关系,提示二者共同参与CRC的发生与发展,联合检测RegⅣ和EGFR可为研究CRC的治疗、生物学行为及预后提供理论依据。 展开更多
关键词 结直肠肿瘤 RegⅣ egfr 组织芯片 免疫组织化学
下载PDF
非小细胞肺癌组织芯片的EGFR免疫组化研究 被引量:4
6
作者 区伟 吴一龙 +4 位作者 戎铁华 谢丹 乔贵宾 王思愚 杨学宁 《肿瘤防治研究》 CAS CSCD 2004年第11期671-673,共3页
目的利用组织芯片技术,结合免疫组化方法,研究上皮生长因子受体(epidermalgrowthfactorreceptor,EGFR)在非小细胞肺癌的免疫组化表达及其对生存率的影响。方法303例非小细胞肺癌石蜡标本制成组织芯片,采用链菌素亲生物素-过氧化物酶法(... 目的利用组织芯片技术,结合免疫组化方法,研究上皮生长因子受体(epidermalgrowthfactorreceptor,EGFR)在非小细胞肺癌的免疫组化表达及其对生存率的影响。方法303例非小细胞肺癌石蜡标本制成组织芯片,采用链菌素亲生物素-过氧化物酶法(SP)进行免疫组化检测,并用SPSS9.0统计软件进行χ2检验和生存分析。结果EGFR阳性表达171例(56.4%),阴性表达132例(43.6%)。有淋巴结转移组的EGFR表达阳性率为62.7%,无淋巴结转移组的48.9%(P<0.05)。鳞癌的EGFR表达阳性率55.6%,腺癌的EGFR表达阳性率58.8%(P>0.05)。EGFR阳性表达组与阴性表达组的生存率比较没有显著性差异(P>0.05)。结论(1)利用组织芯片技术,结合免疫组化可以大规模、快速高效地检测EGFR在非小细胞肺癌组织的表达。(2)非小细胞肺癌有淋巴结转移组的EGFR过表达明显高于没有淋巴结转移组。(3)EGFR过表达对非小细胞肺癌的预后没有影响。 展开更多
关键词 肺肿瘤 组织芯片 免疫组化 egfr
下载PDF
细支气管肺泡癌和肺腺癌EGFR基因扩增的研究 被引量:3
7
作者 宋欣 宋志刚 +2 位作者 吕亚莉 钟梅 李向红 《中国肺癌杂志》 CAS 2009年第8期879-883,共5页
背景与目的分子靶向治疗药物表皮生长因子酪氨酸激酶抑制剂(EGFR-TKI)可提高肺腺癌病人的生存率,不同组织类型疗效不同。本研究对细支气管肺泡癌和经典型肺腺癌中表皮生长因子受体(EGFR)基因扩增情况进行比较分析,为临床预后治疗提供依... 背景与目的分子靶向治疗药物表皮生长因子酪氨酸激酶抑制剂(EGFR-TKI)可提高肺腺癌病人的生存率,不同组织类型疗效不同。本研究对细支气管肺泡癌和经典型肺腺癌中表皮生长因子受体(EGFR)基因扩增情况进行比较分析,为临床预后治疗提供依据。方法根据2004年WHO最新肺肿瘤分类标准选取2004年1月-2006年12月期间中国人民解放军总医院病理科病理档案中细支气管肺泡癌(BAC)27例(男13例、女14例)、经典型肺腺癌23例(男11例、女12例),具有BAC成分的混合亚型肺腺癌39例(男18例,女21例),总计89例。应用组织芯片和荧光原位杂交技术(FISH)进行EGFR基因扩增的检测。结果在经典型肺腺癌病例中EGFR基因的扩增率为45.45%,BAC病例中的EGFR基因的扩增率为14.81%,混合亚型肺腺癌为22.58%。经典型肺腺癌的扩增病例明显多于BAC和混合亚型肺腺癌,三组之间c2=11.632,P<0.05。三组病例中EGFR基因扩增多以散在信号存在。结论EGFR基因在肺腺癌的扩增率高于BAC。 展开更多
关键词 细支气管肺泡癌 肺腺癌 egfr FISH 组织芯片
下载PDF
应用组织芯片研究人肾癌中Survivin、EGFR和PCNA的表达与预后的关系 被引量:3
8
作者 柯莽 周涛 +1 位作者 王天济 翁志梁 《浙江临床医学》 2007年第12期1590-1592,共3页
目的检测Survivin、EGFR和PCNA在人肾癌组织中的表达,以探讨三者在肾癌中表达的相关性及其与预后的关系。方法利用组织芯片技术构建82例肾癌与26例癌旁正常肾组织芯片,应用免疫组织化学Envision法检测Survivin、EGFR和PCNA在肾癌组织中... 目的检测Survivin、EGFR和PCNA在人肾癌组织中的表达,以探讨三者在肾癌中表达的相关性及其与预后的关系。方法利用组织芯片技术构建82例肾癌与26例癌旁正常肾组织芯片,应用免疫组织化学Envision法检测Survivin、EGFR和PCNA在肾癌组织中的表达。结果肾癌中Survivin、EGFR和PCNA的总表达率分别为74.4%(61/82)、57.3%(47/82)和78.0%(64/82),显著高于正常肾组织(P<0.05)。Survivin和PCNA在肾癌中的表达随着病理分级升高而升高,Survivin和EGFR在肾癌中的表达随着临床分期的升高而升高。肾癌的预后与Survivin、EGFR的阳性表达率有关(P<0.05)。Survivin、EGFR、PCNA三者在肾细胞癌的发生发展中关系密切(P<0.01)。结论Survivin、EGFR、PCNA在肾癌中均有过量表达,可能参与肾癌的发生、发展。Survivin、EGFR阳性表达均可以提示肾癌的不良预后。 展开更多
关键词 肾细胞癌 组织芯片 免疫组织化学 Stwvivin egfr PCNA
下载PDF
TGFα、EGFR表达与胰腺癌神经浸润转移的关系 被引量:1
9
作者 陆澄 曾水林 +1 位作者 张郢华 杨鹏 《中国临床医学》 北大核心 2006年第5期763-764,共2页
目的:探讨TGF-α、EGFR表达与胰腺癌神经浸润转移的关系。方法:用免疫组织化学方法检测31例胰腺癌及其对应癌旁组织中TGF-α、EGFR蛋白表达水平。结果:EGFR蛋白表达水平与胰腺癌神经浸润转移相关(P<0.05)。胰腺癌中有神经浸润转移者... 目的:探讨TGF-α、EGFR表达与胰腺癌神经浸润转移的关系。方法:用免疫组织化学方法检测31例胰腺癌及其对应癌旁组织中TGF-α、EGFR蛋白表达水平。结果:EGFR蛋白表达水平与胰腺癌神经浸润转移相关(P<0.05)。胰腺癌中有神经浸润转移者TGF-α、EGF R共同表达为12例(63.16%),无神经浸润转移者共同表达为2例,其间的差异具有统计学意义(P<0.05)。结论:EGFR蛋白的过量表达,TGF-α/EGFR自分泌环可能在胰腺癌神经浸润转移中也起重要作用。 展开更多
关键词 胰腺癌 转化生长因子Α 表皮生长因子受体 神经浸润 免疫组织化学
下载PDF
HNF-1β在胰腺导管腺癌中的表达及其诊断价值
10
作者 魏雪 章如松 +5 位作者 曹阳 程凯 王璇 马恒辉 饶秋 方茹 《诊断病理学杂志》 2024年第1期12-15,共4页
目的检测肝细胞核因子1β(hepatocyte nuclear factor 1β,HNF-1β)在胰腺导管腺癌(pancreatic ductal adenocarcinoma,PDAC)组织中的表达并探讨其诊断价值。方法收集2021-01—2023-0149例PDAC,采用免疫组化EnVision两步法检测HNF-1β、... 目的检测肝细胞核因子1β(hepatocyte nuclear factor 1β,HNF-1β)在胰腺导管腺癌(pancreatic ductal adenocarcinoma,PDAC)组织中的表达并探讨其诊断价值。方法收集2021-01—2023-0149例PDAC,采用免疫组化EnVision两步法检测HNF-1β、CK7、CK20、PAX-8、GATA-3、NapsinA、TTF1、ER、PR、NKX3.1和RCC的表达情况,比较各种肿瘤标记物表达的阳性率。结果HNF-1β阳性率为85.7%(42/49),其中45.2%(19/42)的病例为强阳性,14.3%(6/42)的病例为中等阳性,40.5%(17/42)的病例为弱阳性。CK7阳性率为83.7%(41/49)。CK20阳性率为4.1%(2/49)。PAX-8、GATA-3、Napsin A、TTF1、ER、PR、NKX3.1和RCC均为阴性表达,阳性率为0(0/49)。结论HNF-1β与其他谱系特异性的肿瘤标志物联合使用,可有助于PDAC的诊断和与其他来源的腺癌的鉴别诊断。 展开更多
关键词 胰腺导管腺癌 HNF-1β 组织芯片 免疫组化
下载PDF
β-cat及EGFR在胃癌癌变中的表达及生物学意义
11
作者 杨宏 张仲 《内蒙古医学杂志》 2008年第10期1157-1160,F0004,共5页
目的:探讨β-连环素(β-cat)及表皮生长因子受体(EGFR)在胃癌癌变过程中的表达及生物学意义。方法:建立组织芯片(Tissue Microarry,TMA)技术平台,应用该技术和免疫组织化学SP法检测两种蛋白在胃癌石蜡包埋组织中的表达。结果:组织芯片... 目的:探讨β-连环素(β-cat)及表皮生长因子受体(EGFR)在胃癌癌变过程中的表达及生物学意义。方法:建立组织芯片(Tissue Microarry,TMA)技术平台,应用该技术和免疫组织化学SP法检测两种蛋白在胃癌石蜡包埋组织中的表达。结果:组织芯片制备成功。β-cat在四组中的阳性率分别为93.3%、57.7%、55.0%、49.2%,其中胃癌组、胃上皮非典型增生组、胃炎组与正常组比较差异均有统计学意义(P<0.01、P<0.05和P<0.05)。EGFR在四组中的阳性率分别为6.7%、19.2%、45.0%、56.9%,胃癌组与正常组和胃炎组比较差异具有统计学意义(P<0.01和P<0.05)。胃上皮非典型增生组与正常胃比较差异有统计学意义(P<0.05)。两种蛋白的表达与胃癌的组织分化程度和淋巴结转移显著相关,而与年龄、临床分期等无明显相关(P>0.05)。β-cat与EGFR二者则呈明显负相关(P>0.01)。结论:本研究中β-cat的表达下降与EGFR的表达升高提示二者与胃癌发生密切相关,与胃癌组织分化程度和淋巴结转移密切相关,提示二者表达失衡在胃癌发展中发挥重要作用。因此,联合检测β-cat和EGFR可作为预测胃癌发生和发展的肿瘤标志物。 展开更多
关键词 Β-连环素 表皮生长因子受体 胃癌 组织芯片 免疫组织化学
下载PDF
EGFR在胰腺癌组织芯片中的表达及其临床意义的研究 被引量:3
12
作者 唐来 刘煦禾 +2 位作者 华惠英 杜媛 李峰 《海南医学院学报》 CAS 2011年第7期890-893,896,共5页
目的:探讨表皮生长因子受体EGFR蛋白在胰腺癌组织中的表达及其与胰腺癌临床病理参数和生物学预后的相关性及意义。方法:将88例无术前放化疗史的胰腺癌手术标本和11例非肿瘤性胰腺组织制成组织芯片,采用免疫组化法检测EGFR蛋白的表达情况... 目的:探讨表皮生长因子受体EGFR蛋白在胰腺癌组织中的表达及其与胰腺癌临床病理参数和生物学预后的相关性及意义。方法:将88例无术前放化疗史的胰腺癌手术标本和11例非肿瘤性胰腺组织制成组织芯片,采用免疫组化法检测EGFR蛋白的表达情况,并对随访2个月~6年的54例病例作生存分析。结果:获得1个胰腺癌组织芯片蜡块,含99个位点。EGFR在胰腺癌中的阳性表达率为59.1%(52/88),而11例非肿瘤性胰腺组织中均无EGFR的过度表达(0/11),两者比较差异有统计学意义(P<0.01),且EGFR表达与肿瘤大小及TNM分期相关(P<0.05)。单因素及多因素Cox生存分析显示,EGFR表达与胰腺癌患者预后相关,具有独立的预后意义(P<0.05)。结论:EGFR蛋白表达与胰腺癌临床病理参数及预后密切相关,可能作为胰腺癌的独立预后指标。 展开更多
关键词 胰腺癌 egfr 组织芯片 免疫组织化学
下载PDF
宫颈癌EGFR和VEGF的表达及相关性研究 被引量:9
13
作者 周素英 陈国荣 +4 位作者 冯国飞 潘丹 张品南 杨小敏 夏作利 《中国现代医生》 2014年第2期68-71,共4页
目的探讨宫颈癌中EGFR及VEGF的表达与宫颈癌的关系及其相关性。方法采用免疫组化EnVision法检测80例宫颈癌组织芯片中EGFR和VEGF的表达,分析其与宫颈癌临床病理特征的关系及其间相关性。结果宫颈癌中的EGFR和VEGF阳性表达率分别为94.8%... 目的探讨宫颈癌中EGFR及VEGF的表达与宫颈癌的关系及其相关性。方法采用免疫组化EnVision法检测80例宫颈癌组织芯片中EGFR和VEGF的表达,分析其与宫颈癌临床病理特征的关系及其间相关性。结果宫颈癌中的EGFR和VEGF阳性表达率分别为94.8%、79.1%,癌旁组织中的表达率分别为15%、20%。两者在两种组织中的表达有显著差异(P<0.01)。EGFR表达与肿瘤大小、组织类型、病理分级、浸润深度、淋巴结转移、临床分期有关(P<0.05);VEGF与肿瘤大小、淋巴结转移、临床分期有关(P<0.05);EGFR和VEGF表达两者之间有显著性相关性(r=0.2548,P<0.05)。结论 EGFR和VEGF高表达与宫颈癌的生长、浸润转移及预后有相关性,两者在宫颈癌的发展中可能存在协同作用。 展开更多
关键词 宫颈癌 egfr VEGF 免疫组织化学 组织芯片 靶向治疗
下载PDF
EGFR和DNA-PKcs与肺癌患者预后的关系 被引量:1
14
作者 曲媛媛 殷洪涛 +2 位作者 张茵 王瑞芝 鄂明艳 《中国卫生标准管理》 2019年第14期43-45,共3页
目的检测表皮生长因子受体(epidermal growth factor receptor,EGFR)和DNA依赖蛋白激酶催化亚基(DNA-dependent protein kinase catalytic subunit,DNA-PKcs)表达水平与非小细胞肺癌患者预后的关系。方法将2005年1月-2008年6月在我院手... 目的检测表皮生长因子受体(epidermal growth factor receptor,EGFR)和DNA依赖蛋白激酶催化亚基(DNA-dependent protein kinase catalytic subunit,DNA-PKcs)表达水平与非小细胞肺癌患者预后的关系。方法将2005年1月-2008年6月在我院手术的227例非小细胞肺癌患者根据免疫组化法染色结果分为四组:-、+、++、+++,分别比较EGFR和DNA-PKcs不同表达程度的患者之间生存时间的差异,随访至2018年8月。结果EGFR-、+、++、+++表达的患者例数分别为90例(40%)、50例(22%)、45例(20%)、42例(18%),中位生存时间分别为35、37、35、34个月(P>0.05)。DNA-PKcs-、+、++、+++表达的患者例数分别为59例(26%)、18例(8%)、40例(18%)、110例(48%),中位生存时间分别为37、34、32、33个月,阴性表达(-)和高表达(+++)之间差异具有统计学意义(P<0.05)。EGFR和DNA-PKcs共高表达的有27例。GFR和DNA-PKcs共高表达的患者中位生存时间为27个月,非高表达患者的中位生存时间为36个月,差异不具有统计学意义(P>0.05)。结论EGFR表达对非小细胞肺癌患者的预后无影响,DNA-PKcs阴性表达患者生存时间优于高表达(+++)患者,提示高表达患者的预后不良。 展开更多
关键词 egfr DNA-PKCS 非小细胞肺癌 生存时间 组织芯片 免疫组化 阳性表达
下载PDF
Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma 被引量:5
15
作者 Liu-Hong Pan Min Yao +4 位作者 Yin Cai Juan-Juan Gu Xu-Li Yang Li Wang Deng-Fu Yao 《World Journal of Gastroenterology》 SCIE CAS 2016年第14期3829-3836,共8页
AIM: To investigate member 3a of Wingless-type MMTV integration site family (Wnt3a) expression in cancerous and surrounding tissues and the relationship between clinicopathologic features of hepatocellular carcinoma (... AIM: To investigate member 3a of Wingless-type MMTV integration site family (Wnt3a) expression in cancerous and surrounding tissues and the relationship between clinicopathologic features of hepatocellular carcinoma (HCC) and Wnt3a expression.METHODS: Wnt3a expression and cellular distribution and clinicopathologic characteristics in cancerous tissue and matched surrounding tissues were analyzed in 80 HCC patients from January 2006 to August 2008 by tissue microarrays and immunohistochemistry. The overall and disease-free survival rates were estimated using the Kaplan-Meier method and compared with the log-rank test. The prognostic analysis was carried out with univariate and multivariate Cox regressions models.RESULTS: The incidence of oncogenic Wnt3a expression in the cancerous group was up to 96.25% (77 of 80), which was significantly higher (&#x003c7;<sup>2</sup> = 48.818, P &#x0003c; 0.001) than that in the surrounding group (46.25%, 37 of 80). Brown Wnt3a staining gradually increased with clinical staging that showed very strong staining in advanced HCC. The clinicopathologic features of high Wnt3a expression in HCC were related to poorly-differentiated grade (&#x003c7;<sup>2</sup> = 20.211, P &#x0003c; 0.001), liver cirrhosis (&#x003c7;<sup>2</sup> = 8.467, P &#x0003c; 0.004), hepatitis B virus (HBV) infection (&#x003c7;<sup>2</sup> = 12.957, P &#x0003c; 0.001), higher tumor-node-metastasis stage (&#x003c7;<sup>2</sup> = 22.960, P &#x0003c; 0.001), and 5-year survival rate (&#x003c7;<sup>2</sup> = 15.469, P &#x0003c; 0.001).CONCLUSION: Oncogenic Wnt3a expression associated with HBV infection and cirrhotic liver might be an independent prognostic factor for HCC. 展开更多
关键词 Hepatocellular carcinoma PROGNOSIS WNT3A Wnt/β -catenin signal tissue microarrays immunohistochemistry
下载PDF
Expressions of Poly(ADP-ribose) Glycohydrolase(PARG) and Membrane Type 1 Matrix Metalloproteinase(MT1-MMP) in Colorectal Carcinoma 被引量:1
16
作者 Xian Li Guang-jie Duan +2 位作者 Ya-lan Wang N. Jasmine Fauzee Qiao-zhuan Li 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2010年第3期186-193,共8页
Objective:To investigate the significance of Poly(ADP-ribose) glycolhydrolase(PARG) and membrane type 1 matrix metalloproteinase(MT1-MMP) expressions in human colorectal carcinoma.Methods:Immunohistochemical s... Objective:To investigate the significance of Poly(ADP-ribose) glycolhydrolase(PARG) and membrane type 1 matrix metalloproteinase(MT1-MMP) expressions in human colorectal carcinoma.Methods:Immunohistochemical staining for PARG and MT1-MMP was carried out on colorectal adenoma-carcinoma tissue microarrays containing normal colorectal mucosae,adenoma,adenoma with malignant transformation and adenocarcinoma(total 130 specimens).The expressions of PARG and MT1-MMP in the GLTN [Gallotannin]-treated and GLTN-untreated lovo cells were detected by Western Blot.Results:PARG expression in adenocarcinoma(83.1%) and adenoma with malignant transformation(66.7%) was significantly higher than that in normal colorectal mucosa(10%) and adenoma(10.5%).Expression of MT1-MMp in normal colorectal mucosa and adenoma was negative,while the expression in adenocarcinoma(80.3%) and adenoma with malignant transformation(72.2%) was high.The expressions of PARG and MT1-MMP in adenocarcinoma with metastasis and in late tumor stages were significantly higher than those in adenocarcinoma with no metastasis and in early tumor stages.Thus,PARG expression shows a positive correlation with the expression of MT1-MMP.The expressions of PARG and MT1-MMP in GLTN-treated lovo cells were weaker than that in GLTN-untreated lovo cells.Conclusion:The expression of PARG was probably related to the development of colorectal carcinoma.PARG may play an important role for the regulation of MT1-MMP expression in colorectal carcinoma. 展开更多
关键词 PARG MT1-MMP Colorectal carcinoma tissue microarray immunohistochemistry
下载PDF
Expressions and clinical significance of CD147 and CK19 in hepatocellular carcinoma
17
作者 Weidong Wang Ming Zhao Yujun Li 《The Chinese-German Journal of Clinical Oncology》 CAS 2012年第9期517-521,共5页
Objective: The aim of this study was to investigate the expressions of CD147 and CK19 in hepatocellular car- cinoma (HCC) and their clinical significance. Methods: The expressions of CD147 and CK19 were determined by ... Objective: The aim of this study was to investigate the expressions of CD147 and CK19 in hepatocellular car- cinoma (HCC) and their clinical significance. Methods: The expressions of CD147 and CK19 were determined by tissue microarray and immunohistochemistry (IHC) in 272 cases of HCC and 81 cases of adjacent tumorous tissue. Results: The positive expression of CD147 in HCC and adjacent tumorous tissue was 73.53% (200/272) and 13.58% (11/81) with signifi- cant difference (P < 0.05). The positive expression of CK19 in HCC and adjacent tumorous tissue was 14.34% (39/272) and 0 (0/81) with significant difference (P < 0.05). The positive expression of CD147 were closely correlated to the histological grade, clinical stage, tumor-free survival, diameter of tumor and embolus of cancer in aqueduct or portal vein; but not to the patients' sex, age, liver cirrhosis, AFP level, infection of HBV, lymph node metastasis, number of tumor, invasion liver involucrum and the micro-satellites (P > 0.05). The expression of CK19 in HCC were closely correlate to the tumor-free survival, histological grade, diameter of tumor, liver cirrhosis, micro-satellites, lymph node metastasis and clinical stage; but not to patients' sex, age, number of tumor, invasion liver involucrum, AFP level, infection of HBV and embolus of cancer in aqueduct or portal vein (P > 0.05). Among the patients of positive expression of CD147, the median replacing time and overall survival were 13 and 24 months, lower than 48 and 60 months in the patients of negative expression (P < 0.05). Among the patients of positive expression of CK19, the median replacing time and overall survival were 7 and 13 months, lower than 31 and 42 months in the patients of negative expression (P < 0.05). The expression of CD147 had no correlation with the expression of CK19 (r = 0.061, P = 0.317). Conclusion: The positive of CD147 and CK19 closely correlate with the clinical prognosis of HCC, it may indicate poor prognosis of HCC. 展开更多
关键词 hepatocellular carcinoma (HCC) CD147 CK19 tissue microarray immunohistochemistry (IHC) prognosis
下载PDF
Expression Analysis of Aquaporin-1 (Aqp-1) in Human Biliary Tract Carcinoma
18
作者 Shinichi Sekine Tomoyuki Okumura +5 位作者 Takuya Nagata Kazuto Shibuya Isaku Yoshioka Koshi Matsui Ryouta Hori Kazuhiro Tsukada 《Journal of Cancer Therapy》 2016年第1期17-23,共7页
Background: Aquaporins (AQPs) are important in controlling bile water secretion. AQP is related to the invasion and metastasis of cancer. However, the relationship of biliary tract cancer is not clear. The role of AQP... Background: Aquaporins (AQPs) are important in controlling bile water secretion. AQP is related to the invasion and metastasis of cancer. However, the relationship of biliary tract cancer is not clear. The role of AQP-1 in cancer cell is also unknown. Methhods: We analyzed AQP-1 expression using tissue microarray (TMA) in 99 samples immunohistochemically (50 gallbladder carcinoma, 39 bile duct carcinoma and 10 Papilla Vater carcinoma patients who underwent surgery at our department from 1997 to 2011). Gene expressions were evaluated by the combination of the immunohistological intensity and distribution. The expression level is compared to the clinico-pathological data of the patients. Results: In the TMA, depth of tumor invasion and histological type are associated with AQP-1 expression. The group of patients with high AQP-1 expression is associated with higher rates of disease specific survival (log-rank p = 0.013). Cox’s proportional hazard model reveals that AQP-1 expression is an independent prognostic factor (RR, 0.324;p = 0.001) in multivariate analysis. There is a correlation between AQP-1 expression and tumor invasion. Conclusions: These observations of this study suggest that AQP-1 expression may be favorable biomarkers associated with prognosis and tumor invasion in biliary tract carcinoma. 展开更多
关键词 AQUAPORIN Biliary Tract carcinoma tissue microarray immunohistochemistry
下载PDF
组织微阵列技术研究肿瘤转移相关基因在鼻咽癌中的表达与临床意义 被引量:11
19
作者 范松青 张文玲 +2 位作者 徐丽娜 周艳宏 李桂源 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2009年第5期616-623,共8页
利用高通量组织微阵列结合免疫组化检测MT1-MMP、MT2-MMP、Ezrin、nm23-H1、E-cad和TIMP-2在鼻咽癌组织中的蛋白质表达,探讨肿瘤转移相关基因异常表达在鼻咽癌侵袭转移中的作用,筛选鼻咽癌转移相关分子标志物.结果发现,鼻咽癌组织存在MT... 利用高通量组织微阵列结合免疫组化检测MT1-MMP、MT2-MMP、Ezrin、nm23-H1、E-cad和TIMP-2在鼻咽癌组织中的蛋白质表达,探讨肿瘤转移相关基因异常表达在鼻咽癌侵袭转移中的作用,筛选鼻咽癌转移相关分子标志物.结果发现,鼻咽癌组织存在MT1-MMP、Ezrin蛋白高表达(P<0.01)和nm23-H1、TIMP-2蛋白低表达(P<0.05).临床Ⅱ期、Ⅲ期和Ⅳ期鼻咽癌和淋巴结转移鼻咽癌中MT1-MMP、MT2-MMP和Ezrin蛋白阳性表达显著高于临床Ⅰ期鼻咽癌和无转移癌(P<0.05,P<0.01),但临床Ⅱ期、Ⅲ期和Ⅳ期鼻咽癌和淋巴结转移鼻咽癌中nm23-H1蛋白的阳性表达显著低于临床Ⅰ期鼻咽癌和无转移癌(P<0.05).鼻咽癌组织中MT1-MMP与MT2-MMP(r=0.308,P<0.001),nm23-H1与E-cad(r=0.167,P<0.05)及TIMP-2(r=0.279,P=0.001),E-cad与TIMP-2(r=0.279,P=0.001)的蛋白质表达呈显著正相关.MT1-MMP与E-cad(r=-0.188,P<0.05)及TIMP-2(r=-0.233,P<0.05),Ezrin与E-cad(r=-0.204,P<0.05)的蛋白质表达呈显著性负相关.聚类分析显示,鼻咽癌MT1-MMP、MT2-MMP和Ezrin蛋白共同阳性表达显著高于慢性炎性鼻咽上皮(P<0.05),但nm23-H1、E-cad和TIMP-2蛋白在鼻咽癌组织中的共同阴性显著高于癌旁上皮和慢性炎性鼻咽上皮(P<0.05,P<0.01).多因素分析和有效性评估发现,MT1-MMP蛋白能较好地独立预测鼻咽癌淋巴结转移和临床进展.上述研究结果提示,多个肿瘤转移基因的蛋白质高表达,转移抑制基因的低表达和这些基因的蛋白质表达失平衡在鼻咽癌淋巴结转移和临床进展过程中起重要作用.MT1-MMP蛋白可作为预测鼻咽癌淋巴结转移的较好分子标志. 展开更多
关键词 肿瘤转移相关基因 鼻咽癌 组织微阵列 免疫组化
下载PDF
β-catenin和MMP-7表达与大肠癌侵袭转移的关系研究 被引量:9
20
作者 段光杰 阎晓初 +4 位作者 章容 卞修武 王清良 刘丽梅 陈春燕 《第三军医大学学报》 CAS CSCD 北大核心 2006年第3期227-230,共4页
目的探讨β-链接素(-βcaten in)和基质金属蛋白酶7(m atrix m etalloprote inase-7,MMP-7)表达与大肠癌侵袭转移的关系。方法应用组织芯片和免疫组化技术检测β-caten in和MMP-7在25例大肠正常黏膜及200例腺癌组织的表达。结果腺癌组... 目的探讨β-链接素(-βcaten in)和基质金属蛋白酶7(m atrix m etalloprote inase-7,MMP-7)表达与大肠癌侵袭转移的关系。方法应用组织芯片和免疫组化技术检测β-caten in和MMP-7在25例大肠正常黏膜及200例腺癌组织的表达。结果腺癌组织与正常黏膜相比-βcaten in胞膜表达显著减弱,并出现明显的细胞质和/或细胞核表达,差异有显著性(均为P<0.01)。腺癌组织MMP-7阳性表达率为72.5%,显著高于正常黏膜16.0%(P<0.01)。淋巴结转移阳性、DukesC/D期腺癌组-βcaten in胞膜表达率分别显著低于淋巴结转移阴性及A期组(P<0.05)。β-caten in胞核表达率及MMP-7阳性表达率在溃疡型、淋巴结转移阳性及Dukes C/D期腺癌组分别显著高于息肉型、淋巴结阴性及A/B期组(P<0.05,P<0.01)。193例大肠腺癌组织中-βcaten in细胞质、细胞核表达与MMP-7阳性表达均呈正相关(r=0.319,r=0.290,P<0.01)。结论致瘤性β-caten in与MMP-7协同表达可能在大肠癌的侵袭转移过程中发挥重要作用。溃疡型与息肉型腺癌可能存在不同的生长调控机制。 展开更多
关键词 大肠癌 Β-链接素 金属蛋白酶类 免疫组织化学 组织芯片
下载PDF
上一页 1 2 8 下一页 到第
使用帮助 返回顶部